Literature DB >> 8493749

Surgery of renal cell carcinoma.

D R Couillard1, R W deVere White.   

Abstract

The overwhelming determining factor in survival for renal cell carcinoma is the total surgical removal of the tumor. Preoperative assessment of tumor stage is critical in determining the surgical approach especially regarding the presence and extent of tumor thrombus. Interoperative techniques are discussed as well as parenchymal sparing procedures and the role of surgery in advanced disease.

Entities:  

Mesh:

Year:  1993        PMID: 8493749

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  11 in total

Review 1.  The role of resection for patients with renal carcinoma.

Authors:  R C Flanigan; P M Yonover
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

2.  Phase II trial of suramin in patients with metastatic renal cell carcinoma.

Authors:  R Dreicer; D C Smith; R D Williams; W A See
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.

Authors:  Virginia E Kwitkowski; Tatiana M Prowell; Amna Ibrahim; Ann T Farrell; Robert Justice; Shan Sun Mitchell; Rajeshwari Sridhara; Richard Pazdur
Journal:  Oncologist       Date:  2010-03-23

4.  B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.

Authors:  Amy E Krambeck; R Houston Thompson; Haidong Dong; Christine M Lohse; Eugene S Park; Susan M Kuntz; Bradley C Leibovich; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

5.  Solitary sacral soft tissue metastasis from renal cell carcinoma.

Authors:  Z Sinik; H Biri; O Ataoglu; B Celik; K Karaca; A Paşaoglu
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

6.  Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Authors:  R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Kent G Krejci; John R Lobo; Shomik Sengupta; Lieping Chen; Horst Zincke; Michael L Blute; Scott E Strome; Bradley C Leibovich; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

7.  Cytoreductive Surgery in the Management of Renal Tumours: Rationale, Current Evidence and Future Perspectives.

Authors:  Makarand V Khochikar
Journal:  Indian J Surg Oncol       Date:  2016-12-08

8.  Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

Authors:  John P T Higgins; Rajesh Shinghal; Harcharan Gill; Jeffrey H Reese; Martha Terris; Ronald J Cohen; Michael Fero; Jonathan R Pollack; Matt van de Rijn; James D Brooks
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

9.  Surgical resection for locally invasive renal cell carcinoma: Is it worthwhile?

Authors:  Suraj Manjunath; C Ramachandra; Vijayashree Murthy; Prashanth S Murthy; P S Prabhakaran; V Satya Suresh Attili
Journal:  Indian J Urol       Date:  2007-07

Review 10.  Metastatic renal cell carcinoma.

Authors:  Robert C Flanigan; Steven C Campbell; Joseph I Clark; Maria M Picken
Journal:  Curr Treat Options Oncol       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.